US Stock MarketDetailed Quotes
AMED Amedisys
- 92.080
- -0.350-0.38%
Close May 3 16:00 ET
- 91.660
- -0.420-0.46%
Post 17:20 ET
3.01BMarket Cap-146158P/E (TTM)
92.680High91.862Low246.62KVolume92.430Open92.430Pre Close22.71MTurnover0.77%Turnover RatioLossP/E (Static)32.68MShares96.43652wk High2.77P/B2.94BFloat Cap73.10052wk Low--Dividend TTM31.95MShs Float325.120Historical High--Div YieldTTM0.89%Amplitude0.563Historical Low92.090Avg Price1Lot Size
Amedisys Stock Forum
Sign in to post a comment
$Amedisys(AMED.US$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics(IKT.US$
learn from
$Amedisys(AMED.US$
$AMC Entertainment(AMC.US$
$Fulcrum Therapeutics(FULC.US$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech(PMCB.US$
learn from
$Amedisys(AMED.US$
$AMC Entertainment(AMC.US$
$Fulcrum Therapeutics(FULC.US$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech(PMCB.US$
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Kofi : Do u see it going above 100 ?